부산대학교 도서관

Lobon, I.; Shum, B.; Egan, D.; Fidan, R.; Lesluyes, T.; Jiang, Q.; Pallikonda, H.; Khoja, L.; Nahm, S.H.; El Badri, S.; Peleva, E.; Fusi, A.; Gault, A.C.; Pickering, L.M.; Danson, S.; van Loo, P.; Litchfield, K.R.; Larkin, J.; Lorigan, P.; Turajlic, S.

Immuno-Oncology and Technology. 24

Bowes AL; Cancer Genomics Group, The Francis Crick Institute, London, UK; Sarcoma Biology and Genomics Group, UCL Cancer Institute, London, UK.; Waise S; Cancer Genomics Group, The Francis Crick Institute, London, UK; Cancer Sciences, University of Southampton, Southampton, UK.; Lesluyes T; Cancer Genomics Group, The Francis Crick Institute, London, UK.; Butters T; Sarcoma Biology and Genomics Group, UCL Cancer Institute, London, UK.; English C; Cancer Genomics Group, The Francis Crick Institute, London, UK.; Yan H; Cancer Genomics Group, The Francis Crick Institute, London, UK.; Verfaillie A; Genomics Core, UZ / KU Leuven, Belgium.; Davies C; Sarcoma Biology and Genomics Group, UCL Cancer Institute, London, UK.; Chen J; Sarcoma Biology and Genomics Group, UCL Cancer Institute, London, UK.; Nye E; Experimental Histopathology Science and Technology Platform, The Francis Crick Institute, London, UK.; Stone R; Experimental Histopathology Science and Technology Platform, The Francis Crick Institute, London, UK.; Manji J; Microscopy and Imaging Translational Technology Platform, UCL Cancer Institute, London, UK.; Flanagan AM; Genetics and Cell Biology of Sarcoma, UCL Cancer Institute, London, UK; The Royal National Orthopaedic Hospital NHS Trust, London, UK.; Demeulemeester J; Cancer Genomics Group, The Francis Crick Institute, London, UK; (V)IB Centre for Cancer Biology, Leuven, Belgium; Department of Oncology, KU Leuven, Belgium.; Tarabichi M; Cancer Genomics Group, The Francis Crick Institute, London, UK; Institute for Interdisciplinary Research, Université Libre de Bruxelles, Brussels, Belgium.; Pillay N; Sarcoma Biology and Genomics Group, UCL Cancer Institute, London, UK; The Royal National Orthopaedic Hospital NHS Trust, London, UK.; Van Loo P; Cancer Genomics Group, The Francis Crick Institute, London, UK; Department of Genetics, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA. Electronic address: pvanloo@mdanderson.org.

Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

Hemming, Matthew L.; Lawlor, Matthew A.; Zeid, Rhamy; Lesluyes, Tom; Fletcher, Jonathan A.; Raut, Chandrajit P.; Sicinska, Ewa T.; Chibon, Frédéric; Armstrong, Scott A.; Demetri, George D.; Bradner, James E.

Proceedings of the National Academy of Sciences of the United States of America, 2018 Jun . 115(25), E5746-E5755.

Elena Kuzmin; Toby M. Baker; Tom Lesluyes; Jean Monlong; Kento T. Abe; Paula P. Coelho; Michael Schwartz; Joseph Del Corpo; Dongmei Zou; Genevieve Morin; Alain Pacis; Yang Yang; Constanza Martinez; Jarrett Barber; Hellen Kuasne; Rui Li; Mathieu Bourgey; Anne-Marie Fortier; Peter G. Davison; Atilla Omeroglu; Marie-Christine Guiot; Quaid Morris; Claudia L. Kleinman; Sidong Huang; Anne-Claude Gingras; Jiannis Ragoussis; Guillaume Bourque; Peter Van Loo; Morag Park

Cell Reports, Vol 43, Iss 4, Pp 113988- (2024)

Cross W; Rare Malignancies and Cancer Evolution Group, Centre for Cancer Research, University of Reading, Reading, UK.; Lyskjær I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Davies C; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.; Department of Pathology (Research), UCL Cancer Institute, London, UK.; Bunkum A; Computational Cancer Genomics Group, UCL Cancer Institute, London, UK.; Cancer Metastasis Laboratory, UCL Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Rocha AM; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.; Department of Pathology (Research), UCL Cancer Institute, London, UK.; Lesluyes T; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Amary F; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.; Tirabosco R; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.; Naceur-Lombardelli C; Cancer Metastasis Laboratory, UCL Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Jamal-Hanjani M; Cancer Metastasis Laboratory, UCL Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Pillay N; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.; Department of Pathology (Research), UCL Cancer Institute, London, UK.; Zaccaria S; Computational Cancer Genomics Group, UCL Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Flanagan AM; Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK. a.flanagan@ucl.ac.uk.; Department of Pathology (Research), UCL Cancer Institute, London, UK. a.flanagan@ucl.ac.uk.; Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

Brahmi, M. ; Lesluyes, T. ; Dufresne, A. ; Toulmonde, M. ; Italiano, A. ; Mir, O. ; Le Cesne, A. ; Valentin, T. ; Chevreau, C. ; Bonvalot, S. ; Penel, N. ; Coindre, J.-M. ; Le Guellec, S. ; Le Loarer, F. ; Karanian, M. ; Blay, J.-Y. ; Chibon, F.

In ESMO Open February 2021 6(1)

Jiang Y; Montierth MD; Yu K; Ji S; Tran Q; Liu X; Lal JC; Guo S; Wu A; Dai Y; Shin SJ; Li R; Cao S; Tang Y; Lesluyes T; Kopetz S; Msaouel P; Sood AK; Devonshire G; Jones CM; Ajani J; Subudhi SK; Aparicio A; Sharma P; Shen JP; Kimmel M; Wang JR; Tarabichi M; Fitzgerald RC; Zhu H; Loo PV; Wang W

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Frezza, Anna Maria; Stacchiotti, Silvia; Chibon, F.; Coindre, J.M.; Italiano, Antoine; Romagnosa, Cleofe; Bagué Rosell, Sílvia; Dei Tos, Angelo; Braglia, L.; Palmerini, E.; Quagliuolo, V.; Broto, J.M.; López Pousa, Antonio; Grignani, Giovanni; Brunello, A.; Blay, J.Y.; Beveridge, R.D.; Lugowska, Iwona; Lesluyes, T.; Maestro, R.; Merlo, F.D.; Casali, P.G.; Gronchi, A.; Universitat Autònoma de Barcelona

Le Guellec, S. ; Lesluyes, T. ; Sarot, E. ; Valle, C. ; Filleron, T. ; Rochaix, P. ; Valentin, T. ; Pérot, G. ; Coindre, J.-M. ; Chibon, F.

In Annals of Oncology August 2018 29(8):1828-1835

Fontanges Q; Department of Pathology, Gynecopathology and Senology Clinic, Erasme University Hospital, Brussels, Belgium.; Department of Pathology, Charleroi Hospital, Charleroi, Belgium.; Department of Pathology, Cliniques Universitaires de St Luc, Bruxelles, Belgique, Belgium.; Dubos P; Department of Bioinformatics, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Lesluyes T; Oncosarc, INSERM UMR1037, Cancer Research Center, Toulouse, France.; Laizet Y; Department of Bioinformatics, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Velasco V; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Meléndez B; Department of Pathology, Gynecopathology and Senology Clinic, Erasme University Hospital, Brussels, Belgium.; D'Haene N; Department of Pathology, Gynecopathology and Senology Clinic, Erasme University Hospital, Brussels, Belgium.; Oliva E; James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Young RH; James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Mayeur L; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Rebier F; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Alamé M; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Larmonier C; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Devouassoux-Shisheboran M; Department of Pathology, CHU Lyon Sud, Pierrebenite, France.; Arnould L; Department of Pathology, JF Leclerc Center, Comprehensive Cancer Center, Dijon, France.; Soubeyran I; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Chakiba C; Department of Oncology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Floquet A; Department of Oncology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Babin G; Department of Surgery, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Guyon F; Department of Surgery, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; Mery E; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Le Guellec S; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Noël JC; Department of Pathology, Gynecopathology and Senology Clinic, Erasme University Hospital, Brussels, Belgium.; Croce S; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France.; INSERM U1312 Sarcotarget, Bordeaux, France.; Chibon F; Oncosarc, INSERM UMR1037, Cancer Research Center, Toulouse, France.; Department of Pathology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9007329 Publication Model: Print Cited Medium: Internet ISSN: 1098-2264 (Electronic) Linking ISSN: 10452257 NLM ISO Abbreviation: Genes Chromosomes Cancer Subsets: MEDLINE

A. Dufresne; T. Lesluyes; C. Ménétrier-Caux; M. Brahmi; E. Darbo; M. Toulmonde; A. Italiano; O. Mir; A. Le Cesne; S. Le Guellec; T. Valentin; C. Chevreau; S. Bonvalot; Y.M. Robin; J-M Coindre; C. Caux; J.Y. Blay; F. Chibon

OncoImmunology, Vol 9, Iss 1 (2020)

John, E.; Baker, T.M.; Van Loo, P.; Zhao, X.; Lesluyes, T.; Tarabichi, M.; Gillenwater, A.; Wang, J.R.

In: Scientific Reports. (Scientific Reports, December 2024, 14(1))

Baker TM; The Francis Crick Institute, London, United Kingdom.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Medicine, University of California Los Angeles, Los Angeles, California.; Lai S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lynch AR; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lesluyes T; The Francis Crick Institute, London, United Kingdom.; Yan H; The Francis Crick Institute, London, United Kingdom.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ogilvie HA; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Verfaillie A; The Francis Crick Institute, London, United Kingdom.; Dentro S; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.; Bowes AL; The Francis Crick Institute, London, United Kingdom.; Pillay N; Research Department of Pathology, Cancer Institute, University College London, London, United Kingdom.; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, United Kingdom.; Flanagan AM; Research Department of Pathology, Cancer Institute, University College London, London, United Kingdom.; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, United Kingdom.; Swanton C; The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Oncology, University College London Hospitals, London, United Kingdom.; Spellman PT; Department of Medicine, University of California Los Angeles, Los Angeles, California.; Tarabichi M; The Francis Crick Institute, London, United Kingdom.; Institute for Interdisciplinary Research (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium.; Van Loo P; The Francis Crick Institute, London, United Kingdom.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Huang KK; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Ma H; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Chong RHH; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.; Uchihara T; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Lian BSX; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Zhu F; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.; Sheng T; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore.; Srivastava S; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.; Tay ST; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Sundar R; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore; Department of Haematology-Oncology, National University Health System, Singapore 119074, Singapore.; Tan ALK; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Ong X; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Lee M; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Ho SWT; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore.; Lesluyes T; The Francis Crick Institute, London, UK.; Ashktorab H; Department of Medicine, Howard University, Washington, DC, USA.; Smoot D; Department of Internal Medicine, Meharry Medical College, Nashville, TN, USA.; Van Loo P; The Francis Crick Institute, London, UK; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chua JS; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.; Ramnarayanan K; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore.; Lau LHS; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.; Gotoda T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.; Kim HS; Department of Internal Medicine, Yonsei University Wonju College of Medicine, Seoul, Korea.; Ang TL; Department of Gastroenterology & Hepatology, Changi General Hospital, Singapore 529889, Singapore.; Khor C; Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore 169854, Singapore.; Lee JWJ; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore; iHealthtech, National University of Singapore, Singapore, Singapore; SynCTI, National University of Singapore, Singapore 117599, Singapore; Department of Gastroenterology & Hepatology, National University Hospital, Singapore 119074, Singapore.; Tsao SKK; Department of Gastroenterology & Hepatology, Tan Tock Seng Hospital, Singapore 308433, Singapore.; Yang WL; Department of Gastroenterology & Hepatology, Tan Tock Seng Hospital, Singapore 308433, Singapore.; Teh M; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.; Chung H; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Electronic address: h.chung@snu.ac.kr.; So JBY; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore; NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Division of Surgical Oncology, National University Cancer Institute of Singapore (NCIS), Singapore, Singapore. Electronic address: jimmyso@nus.edu.sg.; Yeoh KG; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore; Department of Gastroenterology & Hepatology, National University Hospital, Singapore 119074, Singapore. Electronic address: mdcykg@nus.edu.sg.; Tan P; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore 169857, Singapore; Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore; Cellular and Molecular Research, National Cancer Centre, Singapore, Singapore; Singhealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore 168752, Singapore. Electronic address: gmstanp@duke-nus.edu.sg.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Nurminen A; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Jaatinen S; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Taavitsainen S; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Högnäs G; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Lesluyes T; The Francis Crick Institute, London, NW1 1AT, UK.; Ansari-Pour N; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Tolonen T; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.; Haase K; The Francis Crick Institute, London, NW1 1AT, UK.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, ECRC Experimental and Clinical Research Center, Berlin, Germany.; Koskenalho A; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Kankainen M; Institute for Molecular Medicine Finland, University of Helsinki, Tukholmankatu 8, Helsinki, 00290, Finland.; Jasu J; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Rauhala H; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Kesäniemi J; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Nikupaavola T; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Kujala P; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.; Rinta-Kiikka I; Imaging Centre, Department of Radiology, Tampere University Hospital, Tampere, Finland.; Riikonen J; Department of Urology, TAYS Cancer Center, Tampere University Hospital, Tampere, Finland.; Kaipia A; Department of Urology, TAYS Cancer Center, Tampere University Hospital, Tampere, Finland.; Murtola T; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Department of Urology, TAYS Cancer Center, Tampere University Hospital, Tampere, Finland.; Tammela TL; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Department of Urology, TAYS Cancer Center, Tampere University Hospital, Tampere, Finland.; Visakorpi T; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.; Nykter M; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland.; Wedge DC; Manchester Cancer Research Centre, Division of Cancer Sciences, University of Manchester, Manchester, M20 4GJ, UK.; Van Loo P; The Francis Crick Institute, London, NW1 1AT, UK.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Bova GS; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, PO Box 100, 33014, Tampere, Finland. steve.bova@tuni.fi.

Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE

Pourebrahim R; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Montoya RH; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Akiyama H; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ostermann L; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khazaei S; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Muftuoglu M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Baran N; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhao R; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lesluyes T; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Liu B; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khoury JD; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, NE, USA.; Gagea M; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mandreef@mdanderson.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Michaud, M.; Pérot, G.; Lesluyes, T.; Desplat, N.; Delespaul, L.; Lucchesi, C.; Neuville, A.; Blay, J.Y.; Coindre, J.M.; Chibon, F.

European Journal of Cancer. 61:S28-S28

Filleron T; Biostatistics Unit, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse Cedex, France. Filleron.thomas@iuct-oncopole.fr.; Le Guellec S; Department of Pathology, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.; Chevreau C; Department of Medical Oncology, Institut Claudius Regaud IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.; Cabarrou B; Biostatistics Unit, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse Cedex, France.; Lesluyes T; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.; Lodin S; Clinical Trials Office, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.; Massoubre A; Clinical Trials Office, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.; Mounier M; Clinical Trials Office, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.; Poublanc M; Clinical Trials Office, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.; Chibon F; Department of Pathology, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.; Valentin T; INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.; Department of Medical Oncology, Institut Claudius Regaud IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Valentin, T. ; Lesluyes, T. ; Le Guellec, S. ; Chibon, F.

In Annals of Oncology January 2019 30(1):153-155

Chatsirisupachai K; Integrative Genomics of Ageing Group, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.; Lesluyes T; The Francis Crick Institute, London, UK.; Paraoan L; Department of Eye and Vision Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.; Van Loo P; The Francis Crick Institute, London, UK.; de Magalhães JP; Integrative Genomics of Ageing Group, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK. jp@senescence.info.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE